Loading clinical trials...
Loading clinical trials...
An Open-Label 12-Week Food Study to Assess the Safety, Tolerability, And Physiological Effects of An Amino Acid Food Product, AXA4010, In Subjects With Sickle Cell Disease.
Conditions
Interventions
AXA4010
Locations
4
United States
Foundation for Sickle Cell Disease Research
Hollywood, Florida, United States
Advanced Pharma CR, LLC
Miami, Florida, United States
Primary Care research
Atlanta, Georgia, United States
Newark Beth Israel Medical Center
Newark, New Jersey, United States
Start Date
September 25, 2019
Primary Completion Date
January 11, 2021
Completion Date
January 11, 2021
Last Updated
April 1, 2021
NCT06647979
NCT03653338
NCT04201210
NCT06250595
NCT03948867
NCT02286154
Lead Sponsor
Axcella Health, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions